Could a simple swab identify ICU patients who spread superbugs?

NCT ID NCT07685132

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study looks at ICU patients who carry carbapenem-resistant bacteria in their gut. Researchers want to see if patients with higher bacterial loads are more likely to contaminate their surroundings and pass the bacteria to others. By measuring bacteria levels in rectal swabs and testing nearby surfaces, the study aims to find ways to better target infection control efforts.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could help identify ICU patients who are most likely to spread drug-resistant bacteria, allowing hospitals to target cleaning and isolation efforts more effectively.
What could go wrong
This is an observational study, not a treatment trial, so it will not directly change patient care. The findings may not apply to other hospitals or bacteria types.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTIMICROBIAL RESISTANCE (AMR) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hospital Italiano de Buenos Aires

    Buenos Aires, Buenos Aires F.D., 1199, Argentina

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.